The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Open accessAbstract
As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mucocutaneous and visceral disease can be lethal if untreated, but most deaths are attributable to visceral leishmaniasis (103).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depending on the species, Leishmania can cause self-healing cutaneous lesions (e.g., L. tropica, L. major, L. mexicana, and L. pifanoi), disfiguring mucocutaneous disease (e.g., L. braziliensis and L. guyanensis), or severe visceral illness (e.g., L. donovani and L. Infantum chagasi).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [103]
Experimental — accuracy not yet measuredIn the citing paper
“we must consider the important zoonotic potential of the diseases studied, as the presence of human infections or risk of infection has already been described (5, 24, 25, 28).”
From Current Distribution of Selected Vector-Borne Diseases in Dogs in Spain (2020) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Cited by 6,884
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Leishmaniasis: current situation and new perspectives
Desjeux, P. M. P. (2004) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,329 · cited 1×
“Reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden, but studies that measure the degree of underreporting are rare [23].”
BackgroundBank, W. (1993) · doi:10.1596/0-1952-0890-0 · Cited by 2,213
King, C. H., Dickman, K. R., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 898 · cited 1×
“The accuracy of this measure depends on the reliability of the incidence, duration, severity and mortality data for a given condition, as well as the underlying assumptions used in the calculations [7,14].”
BackgroundHealth metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E. A., Sachs, S. E., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 822 · cited 1×
“Although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities [1,2].”
BackgroundAlvar, J., Yactayo, S., & Bern, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.004 · Cited by 813 · cited 1×
“This consignment to critical oblivion results from its complex epidemiology and ecology, the lack of simple, easily-applied tools for case management and the paucity of current incidence data, and often results in a failure on the part of policy-makers to recognize its importance [3,4].”
BackgroundDesjeux, P. M. P. (1996) · Clinics in Dermatology · doi:10.1016/0738-081x(96)00057-0 · Cited by 588 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
BackgroundLibrary, W. (2010) · Cited by 584
Flagged first, then by citations
Research works printed but not linked: 1
- AN Maia-Elkhoury, 2007, [Analysis of visceral leishmaniasis reports by the capture-recapture method]., Rev Saude Publica, 41, 931
Cited by
Sorted by citations
Items 701–800 of 1,004
Salih, N. A., van Griensven, J., Chappuis, F., Antierens, A., Mumina, A., Hammam, O., Boulle, P., Alirol, E., Alnour, M., Elhag, M. S., et al. (2014) · Tropical Medicine & International Health · doi:10.1111/tmi.12238 · Cited by 46
Mallick, S., Dutta, A., Dey, S., Ghosh, J., Mukherjee, D., Sultana, S. S., Mandal, S., Paloi, S., Khatua, S., Acharya, K., et al. (2014) · Experimental Parasitology · doi:10.1016/j.exppara.2014.01.002 · Cited by 46
Zhang, C., Lu, X., Du, X.-Q., Jian, J., Shu, L., & Ma, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063124 · Cited by 46
Bezuneh, A., Mukhtar, M. M., Abdoun, A., Tego, T. T., Takele, Y., Diro, E., Jemaneh, A., Shiferaw, W., Wondimu, H., Bhatia, A., et al. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0759 · Cited by 46
Roy, S., Kumar, G. A., Jafurulla, M., Mandal, C., & Chattopadhyay, A. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.04.017 · Cited by 46
Dupé, A., Dumas, C., & Papadopoulou, B. (2013) · Molecular Microbiology · doi:10.1111/mmi.12478 · Cited by 45
Host-biting rate and susceptibility of some suspected vectors to Leishmania braziliensis
Diniz, M. M. C. D. S. L., Galvis‐Ovallos, F., Gomes, C. M. D. C., Lavitschka, C. D. O., & Galati, E. A. B. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-139 · Cited by 46
Leishmania amazonensis Engages CD36 to Drive Parasitophorous Vacuole Maturation
Okuda, K., Tong, M., Brian, D., Moore, K. J., Gazzinelli, R. T., & Silverman, N. S. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005669 · Cited by 46
Duarte, M. C., Lage, L. M. D. R., Lage, D. P., Martins, V. T., Carvalho, A. M. R. S., Roatt, B. M., Menezes‐Souza, D., Tavares, C. A. P., Alves, R. J., Barichello, J. M., et al. (2016) · Parasitology International · doi:10.1016/j.parint.2016.07.005 · Cited by 46
Ceccarelli, M., Galluzzi, L., Diotallevi, A., Andreoni, F., Fowler, H., Petersen, C. A., Vitale, F., & Magnani, M. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2181-x · Cited by 46
Zackay, A., Cotton, J. A., Sanders, M. J., Hailu, A., Nasereddin, A., Warburg, A., & Jaffe, C. L. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007133 · Cited by 46
Oliaee, R. T., Sharifi, I., Afgar, A., Kareshk, A. T., Asadi, A., Heshmatkhah, A., Bamorovat, M., Jafarzadeh, A., Mohammadi, M. A., & Daneshvar, H. (2018) · Tropical Medicine & International Health · doi:10.1111/tmi.13062 · Cited by 46
Dias, D. S., Ribeiro, P. A. F., Martins, V. T., Lage, D. P., Costa, L. E., Chávez‐Fumagalli, M. Á., Ramos, F. F., Santos, T. T. O., Ludolf, F., de Oliveira, J. S., et al. (2018) · Translational research · doi:10.1016/j.trsl.2018.05.001 · Cited by 46
Sunyoto, T., Verdonck, K., Safi, S. E., Potet, J., Picado, A., & Boelaert, M. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006914 · Cited by 46
Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019: a retrospective analysis
der Auwera, G. V., Davidsson, L., Buffet, P. A., Ruf, M.-T., Gramiccia, M., Varani, S., Chicharro, C., Bart, A., Harms, G., Chiodini, P. L., et al. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.4.2002028 · Cited by 46
Suárez, M., Valencia, B. M., Jara, M., Alba, M., Boggild, A. K., Dujardin, J., Llanos‐Cuentas, A., Arévalo, J., & Adaui, V. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003936 · Cited by 46
Novel CRISPR-based detection of Leishmania species
Dueñas, E., Nakamoto, J. A., Cabrera-Sosa, L., Huaihua, P., Cruz, M., Arévalo, J., Milón, P., & Adaui, V. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.958693 · Cited by 43
“6 million new cases occurring annually (Alvar et al., 2012).”
Malaria and leishmaniasis: Updates on co-infection
Ornellas-Garcia, U., Cuervo, P., & Ribeiro-Gomes, F. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122411 · Cited by 45
“It is estimated that 700,000 to 1 million new cases occur annually, and 1 billion people live in endemic areas and are at risk of infection (8) Endemic in 98 countries and 3 territories (49), in tropical and subtropical regions and in the Mediterranean basin, leishmaniasis is associated with lack of financial resource…”
BackgroundÖzbilgin, A., Çulha, G., Uzun, S., Harman, M., Topal, S. G., Okudan, F., Zeyrek, F. Y., Gündüz, C., Östan, İ., Karakuş, M., et al. (2016) · Tropical Medicine & International Health · doi:10.1111/tmi.12698 · Cited by 45
Yizengaw, E., Getahun, M., Tajebe, F., Cervera, E. C., Adem, E., Mesfin, G., Hailu, A., der Auwera, G. V., Yardley, V., Lemma, M., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00517 · Cited by 45
Kuhlmann, F., Robinson, J. I., Bluemling, G. R., Ronet, C., Fasel, N. J., & Beverley, S. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619114114 · Cited by 45
Montalvo, A. M., Fraga, J., Tirado-Duarte, D., Blandón, G., Alba, A., der Auwera, G. V., Vélez, I. D., & Muskus, C. (2017) · Parasitology Research · doi:10.1007/s00436-017-5454-6 · Cited by 45
Vivarini, Á. D. C., Calegari-Silva, T., Saliba, A. M., Boaventura, V. S., França‐Costa, J., Khouri, R., Dierckx, T., Teixeira, K. L. D., Fasel, N. J., Barral, A. M. P., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01127 · Cited by 44
García, E., Coa, J. C., Otero, E., Cardá, M., Vélez, I. D., Robledo, S. M., & Cardona‐Galeano, W. (2017) · Medicinal Chemistry Research · doi:10.1007/s00044-017-2076-6 · Cited by 45
Karunaweera, N. D., & Ferreira, M. U. (2018) · Parasitology · doi:10.1017/s0031182018000471 · Cited by 45
Miranda-Sapla, M. M., Tomiotto‐Pellissier, F., Assolini, J. P., Carloto, A. C. M., Bortoleti, B. T. D. S., Gonçalves, M. D., Tavares, E. R., Rodrigues, J. H. D. S., Simão, A. N. C., Yamauchi, L. M., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.049 · Cited by 45
Ospina‐Villa, J. D., Hoyos, C. G., Zuluaga, R., & Triana‐Chávez, O. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.05.004 · Cited by 45
Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani
Veronica, J., Chandrasekaran, S., Alti, D., Devender, M., Prajapati, V. K., Sundar, S., & Maurya, R. (2019) · FEBS Journal · doi:10.1111/febs.14923 · Cited by 45
Rodrigues, L. S., Barreto, A. S., Bomfim, L. G. S., Gomes, M. C., Ferreira, N. L. C., da Cruz, G. S., Magalhães, L. S., de Jesus, A. R., Palatnik-de-Sousa, C. B., Corrêa, C. B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.773983 · Cited by 44
Laverde-Paz, M. J., Echeverry, M. C., Patarroyo, M. A., & Bello, F. J. (2017) · Acta Tropica · doi:10.1016/j.actatropica.2017.09.033 · Cited by 44
The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates
Volpedo, G., Bhattacharya, P., Gannavaram, S., Pacheco‐Fernández, T., Oljuskin, T., Dey, R., Satoskar, A. R., & Nakhasi, H. L. (2022) · Pathogens · doi:10.3390/pathogens11040431 · Cited by 44
Martins, V. T., Duarte, M. C., Chávez‐Fumagalli, M. Á., Menezes‐Souza, D., Coelho, C. S. P., de Magalhães-Soares, D. F., Fernandes, A. P., Soto, M., Tavares, C. A. P., & Coelho, E. A. F. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0964-5 · Cited by 44
Antileishmanial Activity of Medicinal Plants Used in Endemic Areas in Northeastern Brazil
de Queiroz, A. C., Dias, T. D. L. M. F., da Matta, C. B. B., Silva, L. H. A. C., de Araújo‐Júnior, J. X., de Araújo, G. B., Moura, F. D. B. P., & Alexandre‐Moreira, M. S. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/478290 · Cited by 44
Mesquita, J. T., Costa‐Silva, T. A., Borborema, S. E. T., & Tempone, A. G. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1954-6 · Cited by 44
Costa, L. E., Goulart, L. R., Pereira, N. C. D. J., Lima, M. I. S., Duarte, M. C., Martins, V. T., Lage, P. S., Menezes‐Souza, D., Ribeiro, T. G., Melo, M. N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110014 · Cited by 45
Leishmaniases in Maghreb: An endemic neglected disease
Chaara, D., Haouas, N., Dedet, J. P., Babba, H., & Pratlong, F. (2014) · Acta Tropica · doi:10.1016/j.actatropica.2013.12.018 · Cited by 44
Antileishmanial Potential of Tropical Rainforest Plant Extracts
Monzote, L., Piñón, A., & Setzer, W. N. (2014) · Medicines · doi:10.3390/medicines1010032 · Cited by 45
Das, A., & Ali, N. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003091 · Cited by 44
Otero, E., Vergara, S., Robledo, S. M., Cardona, W., Cardá, M., Vélez, I. D., Rojas, C. A., & Otálvaro, F. (2014) · Molecules · doi:10.3390/molecules190913251 · Cited by 46
Fonseca-Silva, F., Inacio, J. D. F., Canto‐Cavalheiro, M. M., Menna‐Barreto, R. F. S., & de Almeida-Amaral, E. E. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004442 · Cited by 44
Mandal, A., Das, S., Roy, S., Ghosh, A. K., Sardar, A. H., Verma, S., Saini, S., Singh, R., Abhishek, K., Kumar, A., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004373 · Cited by 44
Bitencourt, J. J. D. G., Pazin, W. M., Ito, A. S., Barioni, M. B., Pinto, C. D. P., dos Santos, M. A., Guimarães, T. H. S., dos Santos, M. R. M., & Valduga, C. J. (2016) · Biophysical Chemistry · doi:10.1016/j.bpc.2016.07.005 · Cited by 44
Sharafi, M., Ghaem, H., Tabatabaee, H. R., & Faramarzi, H. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.12.007 · Cited by 44
Ghatee, M. A., Haghdoost, A. A., Kooreshnia, F., Kanannejad, Z., Parisaie, Z., Karamian, M., & Moshfe, A. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2017.12.004 · Cited by 44
Parasite Biology: The Reservoir Hosts
Maia, C., Dantas‐Torres, F., & Campino, L. (2018) · Springer eBooks · doi:10.1007/978-3-319-72386-0_4 · Cited by 44
Awareness and control of canine leishmaniosis: A survey among Spanish and French veterinarians
Rutte, E. A. L., van Straten, R., & Overgaauw, P. A. M. (2018) · Veterinary Parasitology · doi:10.1016/j.vetpar.2018.01.013 · Cited by 44
Molecular diagnosis of protozoan parasites by Recombinase Polymerase Amplification
Castellanos-González, A., White, A. C., Melby, P. C., & Travi, B. L. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.02.002 · Cited by 44
Espada, C. R., Ortíz, P. A., Shaw, J. J., Barral, A. M. P., Costa, J. M. L., Uliana, S. R. B., & Coelho, A. C. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.03.004 · Cited by 44
Dhom-Lemos, L. D. C., Viana, A. G., Reis-Cunha, J. L., Cardoso, M. S., Mendes, T. A. D. O., Pinheiro, G. R. G., Siqueira, W. F., Lobo, F. P., Teles, L. D. F., Bueno, L. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211719 · Cited by 44
Pathogen Evasion of Chemokine Response Through Suppression of CXCL10
Antonia, A. L., Alvarez, M. I., Trahair, E. D., Gibbs, K. D., Pittman, K. J., Barnes, A. B., Smith, J. S., Rajagopal, S., Thompson, J. W., Reinhardt, R. L., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00280 · Cited by 41
Non-LeishmaniaParasite in Fatal Visceral Leishmaniasis–Like Disease, Brazil
Maruyama, S. R., de Santana, A. K. M., Takamiya, N. T., Takahashi, T. Y., Rogerio, L. A., Oliveira, C. A. B., Milanezi, C. M., Trombela, V. A., Cruz, Â. K., de Jesus, A. R., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2511.181548 · Cited by 44
Human leishmaniasis vaccines: Use cases, target population and potential global demand
Malvolti, S., Malhame, M., Mantel, C. F., Rutte, E. A. L., & Kaye, P. M. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009742 · Cited by 44
Rodrigues, I. A., Azevedo, M. M. B., Chaves, F. C. M., Alviano, C. S., Alviano, D. S., & Vermelho, A. B. (2014) · BioMed Research International · doi:10.1155/2014/985171 · Cited by 44
Díaz‐Sáez, V., Merino‐Espinosa, G., Morales‐Yuste, M., Corpas‐López, V., Pratlong, F., Morillas‐Márquez, F., & Martín‐Sánchez, J. (2014) · Veterinary Parasitology · doi:10.1016/j.vetpar.2014.03.029 · Cited by 49
Espir, T. T., Guerreiro, T. S., Naiff, M. D. F., Figueira, L. D. P., Soares, F. V., da Silva, S. S., & Franco, A. M. R. (2016) · Experimental Parasitology · doi:10.1016/j.exppara.2016.04.010 · Cited by 43
Anjum, A., Shabbir, K., Din, F. U., Shafique, S., Zaidi, S. S., Almari, A. H., Alqahtani, T., Maryiam, A., Khan, M. M., Fatease, A. M. A., et al. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2173335 · Cited by 43
“Despite being among the top 10 individual disease burden, Leishmaniasis has been ignored globally (Alvar et al., 2012).”
BackgroundEvolution and species discrimination according to the Leishmania heat-shock protein 20 gene
Fraga, J., Montalvo, A. M., der Auwera, G. V., Maes, I., Dujardin, J., & Requena, J. M. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.05.020 · Cited by 43
HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals
van Griensven, J., Diro, E., López‐Vélez, R., Boelaert, M., Lynen, L., Zijlstra, E. E., Dujardin, J., & Hailu, A. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70348-1 · Cited by 43
Machado-Silva, A., Guimarães, P. P. G., Tavares, C. A. P., & Sinisterra, R. D. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.993969 · Cited by 44
Species diversity of sand flies and ecological niche model of Phlebotomus papatasi in central Iran
Abedi-Astaneh, F., Akhavan, A. A., Shirzadi, M. R., Rassi, Y., Yaghoobi‐Ershadi, M. R., Hanafi‐Bojd, A. A., Akbarzadeh, K., Nafar-Shalamzari, R., Parsi, S., Abbasi, A. R., et al. (2015) · Acta Tropica · doi:10.1016/j.actatropica.2015.05.030 · Cited by 42
Naman, C. B., Gromovsky, A. D., Vela, C. M., Fletcher, J. N., Gupta, G., Varikuti, S., Zhu, X., Zywot, E. M., Chai, H., Werbovetz, K. A., et al. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01131 · Cited by 43
Silva, R. D. F. E., Ferreira, L. F., Hernandes, M. Z., de Brito, M. E. F., de Oliveira, B. C., da Silva, A. A., Neto, O. P. D. M., Rezende, A. M., & Pereira, V. R. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00327 · Cited by 43
Das, V. N. R., Pandey, R. N., Siddiqui, N. A., Chapman, L. A. C., Kumar, V., Pandey, K., Matlashewski, G., & Das, P. K. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005196 · Cited by 43
Coa, J. C., García, E., Cardá, M., Agut, R., Vélez, I. D., Muñoz, J. A., Yepes, L. M., Robledo, S. M., & Cardona‐Galeano, W. (2017) · Medicinal Chemistry Research · doi:10.1007/s00044-017-1846-5 · Cited by 43
Visceral leishmaniosis in immunocompromised host: an update and literature review
Pagliano, P., & Esposito, S. (2017) · Journal of Chemotherapy · doi:10.1080/1120009x.2017.1323150 · Cited by 43
Halada, P., Hlavačková, K., Risueño, J., Berriatua, E., Volf, P., & Dvořák, V. (2018) · Medical and Veterinary Entomology · doi:10.1111/mve.12305 · Cited by 43
Biomarkers of Cutaneous Leishmaniasis
Bahrami, F., Harandi, A. M., & Rafati, S. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00222 · Cited by 43
Cantanhêde, L. M., Fernandes, F. G., Ferreira, G. E. M., Porrozzi, R., Ferreira, R. D. G. M., & Cupolillo, E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198727 · Cited by 43
Bennai, K., Tahir, D., Lafri, I., Bendjaballah-Laliam, A., Bitam, I., & Parola, P. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006513 · Cited by 43
Toepp, A. J., Larson, M., Wilson, G., Grinnage‐Pulley, T., Bennett, C., Lima, A. L., Anderson, B., Parrish, M., Anderson, M. G., Fowler, H., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.087 · Cited by 43
Plant-feeding phlebotomine sand flies, vectors of leishmaniasis, prefer Cannabis sativa
Abbasi, I., Queiroz, A. T. L., Kirstein, O. D., Nasereddin, A., Horwitz, B. Z., Hailu, A., Salah, I., Mota, T. F., Fraga, D. B. M., Veras, P. S. T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810435115 · Cited by 43
Medkour, H., Davoust, B., Dulieu, F., Maurizi, L., Lamour, T., Marié, J., & Mediannikov, O. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007456 · Cited by 43
Valle, I. V., Machado, M. E., Araújo, C. D. C. B., Cunha‐Júnior, E. F., Pacheco, J. D. S., Torres-Santos, E. C., da Silva, L. C. R. P., Cabral, L. M., do Carmo, F. A., & Sathler, P. C. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab373e · Cited by 43
Pareyn, M., den Bosch, E. V., Girma, N., Houtte, N. V., Dongen, S. V., der Auwera, G. V., Massebo, F., Shibru, S., & Leirs, H. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007667 · Cited by 44
Immunometabolism of Leishmania granulomas
Saunders, E. C., & McConville, M. J. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12394 · Cited by 43
A historical review of the role of cytokines involved in leishmaniasis
Mirzaei, A., Maleki, M., Masoumi, E., & Maspi, N. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155297 · Cited by 43
Mohebali, M., Keshavarz, H., Shirmohammad, S., Akhoundi, B., Borjian, A., Hassanpour, G., Mamishi, S., & Mahmoudi, S. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05558-7 · Cited by 43
Karimi, T., Sharifi, I., Aflatoonian, M. R., Aflatoonian, B., Mohammadi, M. A., Salarkia, E., Babaei, Z., Zarrinkar, F., Sharifi, F., Hatami, N., et al. (2021) · Parasites & Vectors · doi:10.1186/s13071-021-04619-3 · Cited by 43
Erber, A. C., Sandler, P. J., de Avelar, D. M., Swoboda, I., Cota, G., & Walochnik, J. (2022) · Parasites & Vectors · doi:10.1186/s13071-021-05133-2 · Cited by 46
Srivastava, P. K., Gidwani, K., Picado, A., der Auwera, G. V., Tiwary, P., Ostyn, B., Dujardin, J., Boelaert, M., & Sundar, S. (2013) · Tropical Medicine & International Health · doi:10.1111/tmi.12085 · Cited by 42
Infectious diseases in North Africa and North African immigrants to Europe
Khyatti, M., Trimbitas, R.-D., Zouheir, Y., Benani, A., Messaoudi, M. D. E., & Hemminki, K. (2014) · European Journal of Public Health · doi:10.1093/eurpub/cku109 · Cited by 42
In vitro and in vivo antileishmanial effects of aloe-emodin on Leishmania major
Dalimi, A., Delavari, M., Ghaffarifar, F., & Sadraei, J. (2015) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2014.11.004 · Cited by 42
Pinto, É. G., Santos, I. O., Schmidt, T. J., Borborema, S. E. T., Ferreira, V. F., da Rocha, D. R., & Tempone, A. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105127 · Cited by 42
Gouzelou, E., Haralambous, C., Αντωνίου, Μ., Christodoulou, V., Martinković, F., Živičnjak, T., Smirlis, D., Pratlong, F., Dedet, J.-P., Özbel, Y., et al. (2013) · Parasites & Vectors · doi:10.1186/1756-3305-6-342 · Cited by 42
Qualls, W. A., Müller, G. C., Khallaayoune, K., Revay, E. E., Zhioua, E., Kravchenko, V. D., Arheart, K. L., Xue, R., Schlein, Y., Hausmann, A., et al. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0671-2 · Cited by 44
Barhoumi, W., Farès, W., Cherni, S., Derbali, M., Dachraoui, K., Chelbi, I., Ramalho-Ortigão, M., Beier, J. C., & Zhioua, E. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13030329 · Cited by 42
Conceição, J., Davis, R. E., Carneiro, P. P., Giudice, Â., Muniz, A. C., Wilson, M. E., Carvalho, E. M., & Bacellar, O. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004715 · Cited by 42
Chowdhury, R., Kumar, V., Mondal, D., Das, M. L., Das, P. K., Dash, A. P., & Kroeger, A. (2016) · Pathogens and Global Health · doi:10.1080/20477724.2016.1180775 · Cited by 41
In Vitro Antileishmanial Activity of Sterols from Trametes versicolor (Bres. Rivarden)
Lara, V. L., Fidalgo, L. M., Pferschy‐Wenzig, E., Kunert, O., Lima, C. N., & Bauer, R. (2016) · Molecules · doi:10.3390/molecules21081045 · Cited by 42
Ogungbe, I. V., & Setzer, W. N. (2016) · Molecules · doi:10.3390/molecules21101389 · Cited by 42
Antileishmanial activity of meroditerpenoids from the macroalgae Cystoseira baccata
de Sousa, C. B., Gangadhar, K. N., Morais, T. R., Conserva, G. A. A., Vizetto‐Duarte, C., Pereira, H., Laurenti, M. D., Campino, L., Levy, D., Uemi, M., et al. (2017) · Experimental Parasitology · doi:10.1016/j.exppara.2017.01.002 · Cited by 42
Coughlan, S., Mulhair, P. O., Sanders, M. J., Schönian, G., Cotton, J. A., & Downing, T. (2017) · Scientific Reports · doi:10.1038/srep43747 · Cited by 42
Ramezankhani, R., Hosseini, A., Sajjadi, N., Khoshabi, M., & Ramezankhani, A. (2017) · Spatial and Spatio-temporal Epidemiology · doi:10.1016/j.sste.2017.03.003 · Cited by 42
Salguero, F. J., García‐Jiménez, W., Lima, I. D. S., & Seifert, K. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-2624-z · Cited by 42
Bocxlaer, K. V., Gaukel, E., Hauser, D., Park, S. H., Schock, S., Yardley, V., Randolph, R., Plattner, J. J., Merchant, T., Croft, S. L., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02419-17 · Cited by 42
Gomes‐Alves, A. G., Maia, A. F., Cruz, T., Castro, H., & Tomás, A. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201747 · Cited by 42
Gunaratna, G. P. S., Manamperi, A., Böhlken-Fascher, S., Wickremasinghe, R., Gunawardena, K., Yapa, B., Pathirana, N., Pathirana, H., de Silva, N., Sooriyaarachchi, M., et al. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-3238-1 · Cited by 42
Rodrigues, M., Brito-Sousa, J. D., Dias, Á. L. B., Monteiro, W. M., & Sampaio, V. D. S. (2018) · Tropical Medicine & International Health · doi:10.1111/tmi.13196 · Cited by 42
Polari, L. P. M., Carneiro, P. P., Macedo, M. N., Machado, P. R. L., Scott, P., Carvalho, E. M., & Bacellar, O. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00120 · Cited by 42
Afrin, F., Chouhan, G., Islamuddin, M., Want, M. Y., Ozbak, H. A., & Hemeg, H. A. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007227 · Cited by 42
Metadata
- Authors
- Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team
- Affiliations
- World Health Organization (CH)
- Universidad de Antioquia (CO)
- Centers for Disease Control and Prevention (US)
- Instituto de Salud Carlos III (ES)
- Corresponding author
- Alvar, Jorge
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-31
- Volume
- 7
- Issue
- 5
- Pages
- e35671
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3365071
- OpenAlex
- W2107915297
- Cited by
- 5,141
- References
- 51
- Citations by year
- 2026: 177 · 2025: 229 · 2024: 257 · 2023: 305 · 2022: 358 · 2021: 456 · 2020: 468 · 2019: 458 · 2018: 515 · 2017: 440 · 2016: 465 · 2015: 361 · 2014: 404 · 2013: 200 · 2012: 38
- FWCI
- 310.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Sanofi
- Universidad de Medellín
- Pan American Health Organization
- Agencia Española de Cooperación Internacional para el Desarrollo
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › Brucella: diagnosis, epidemiology, treatment
- Keywords
- leishmaniasis, visceral leishmaniasis, cutaneous leishmaniasis, leishmaniasis incidence, country profile, leishmaniasis control, leishmaniasis treatment, access to medicines, neglected tropical diseases, case data
- MeSH terms
- Female, Geography, Humans, Leishmaniasis, Male, Time Factors, World Health Organization, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review